The store will not work correctly when cookies are disabled.
N-(4-amino-3-(trifluoromethyl)phenyl)-4-ethylbenzenesulfonamide
ID: ALA4743951
PubChem CID: 156635004
Max Phase: Preclinical
Molecular Formula: C15H15F3N2O2S
Molecular Weight: 344.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1ccc(S(=O)(=O)Nc2ccc(N)c(C(F)(F)F)c2)cc1
Standard InChI: InChI=1S/C15H15F3N2O2S/c1-2-10-3-6-12(7-4-10)23(21,22)20-11-5-8-14(19)13(9-11)15(16,17)18/h3-9,20H,2,19H2,1H3
Standard InChI Key: UQDWJMZFFRYYMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
24.5281 -15.5720 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1237 -14.8663 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.7147 -15.5694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5420 -14.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5409 -15.6858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2489 -16.0947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9586 -15.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9557 -14.8626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2471 -14.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8342 -14.4578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.4188 -14.4582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4222 -13.6404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7152 -13.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0067 -13.6408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0095 -14.4623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7170 -14.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6669 -16.0928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2487 -16.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5409 -17.3204 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.9563 -17.3207 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.2409 -17.7264 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.2983 -13.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5912 -13.6431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
4 10 1 0
10 2 1 0
2 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
7 17 1 0
6 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
14 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.36 | Molecular Weight (Monoisotopic): 344.0806 | AlogP: 3.65 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.42 | CX Basic pKa: 2.35 | CX LogP: 3.47 | CX LogD: 3.43 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.83 | Np Likeness Score: -1.63 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |